Phase Ib trial of varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced gastric cancer (AGC).

Yunbeom Sang,Minkyu Jung,Hyo Song Kim,Beodeul Kang,Choong-kun Lee,Hyun Cheol Chung,Sun Young Rha

Phase Ib trial of varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced gastric cancer (AGC).

2021

Yunbeom Sang
Minkyu Jung
Hyo Song Kim
Beodeul Kang
Choong-kun Lee
Hyun Cheol Chung
Sun Young Rha

227Background: EGFR and HER2 are over-expressed in gastric cancer, and activation of EGFR signaling in HER2-overexpressing gastric cancer can confer resistance to HER2-directed treatment like trast...

Keywords:

Medicine
Cancer
Cancer research
weekly paclitaxel
VARLITINIB
advanced gastric cancer
egfr signaling

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations